Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advaite, Airehealth, Rheonix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus Medical, Biotronik, Canary Health Technologies, DDF, Durect, Eurofins, Evonik, Seaspine, Sherlock Biosciences, Smartshape Design.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerus, Precigen.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allogene, Alzecure, Antengene, Artiva, Chimerix, Immunicum, Kronos, Lipocine, Neuren, Novo Nordisk, Scpharmaceuticals, Scynexis, Sol-Gel, Viracta, Yiling.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3D Med, Accord Healthcare, Adelia, Aeterna, Aligos, Alloy, Astellas, Aurigene, Bioxcel, Boehringer, Bridgebio, Catalent, Consilient, Cybin, Exelixis, Eyam, Genscript, Gilead, Initium, Janssen, Kalivir, Marinus, Matinas, Maze, Menarini, Merck, Moderna, Nabriva, Orexo, Orsenix, Passage Bio, Pfizer, Postera, Proxygen, Qilu, Roivant, Sellas, Seqirus, Sesen Bio, Sherlock, Sinovant, Syneos, Syros, VBI, Xencor.

The latest global regulatory news, changes and updates affecting biopharma, including: FDA, industry prepare for vaccine; FDA updates trial guidance; Labeling changes for diabetes drugs.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avinger, Australian Biotechnologies, Elixirgen, Flowmetric, Onegevity, RenalytixAI, Ricoh, Sherlock Biosciences, Shockwave Medical, Spartech, The Commons Project, Theracell, Tolo Biotech, Tufpak.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Apeiron, Ascletis, Clover, Cortexyme, Precision, Takeda, Sutro.